홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

전통

Tradipitant

HCID 9916461
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
622370-35-8
표준 SMILES
O=C(c1ccccc1Cl)c1cccnc1-c1nnn(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1-c1ccncc1
InChIKey
CAVRKWRKTNINFF-UHFFFAOYSA-N
분자식
C28H16ClF6N5O
평균 분자량
587.9 g/mol
단동위원소 질량
587.0947568

개요

Tradipitant is a selective, high-affinity antagonist at human substance P/neurokinin-1 (NK-1) receptors. NK-1 receptors are expressed in the brainstem and nucleus tractus solitarius, which receives emetogenic signals from various stimuli including dizziness and vertigo. Approved by the FDA on December 30, 2025, tradipitant is indicated for the prevention of vomiting induced by motion. Tradipitant has also been investigated in gastroparesis,COVID-19-induced pneumonia, and atopic dermatitis.

이름 및 식별자

우선 이름
Tradipitant
IUPAC
[2-[1-[[3,5-bis(trifluoromethyl)phenyl]methyl]-5-pyridin-4-yltriazol-4-yl]-3-pyridinyl]-(2-chlorophenyl)methanone
현지명
전통
영어명
Tradipitant
분자식
C28H16ClF6N5O
분자량
587.9

이름 및 동의어

Tradipitant622370-35-8LY686017LY-686017VLY-686NY0COC51FI[2-[1-[[3,5-bis(trifluoromethyl)phenyl]methyl]-5-pyridin-4-yltriazol-4-yl]pyridin-3-yl]-(2-chlorophenyl)methanoneDTXSID801045805Methanone, (2-(1-((3,5-bis(trifluoromethyl)phenyl)methyl)-5-(4-pyridinyl)-1H-1,2,3-triazol-4-yl)-3-pyridinyl)(2-chlorophenyl)-tradipitantum(2-(1-((3,5-bis(trifluoromethyl)phenyl)methyl)-5-pyridin-4-yltriazol-4-yl)pyridin-3-yl)-(2-chlorophenyl)methanoneMethanone, [2-[1-[[3,5-bis(trifluoromethyl)phenyl]methyl]-5-(4-pyridinyl)-1H-1,2,3-triazol-4-yl]-3-pyridinyl](2-chlorophenyl)-
이름 더 보기
전통(2-bromopyridin-3-yl)(2-chlorophenyl)methanoneVLY 686BiafunginTradipitant APITradipitant(VLY-686)Tradipitant, 10 mM in DMSOtradipitant,VLY-686, LY686017
RefChem:933246DTXCID6015277342-(1-((3,5-bis(trifluoromethyl)phenyl)methyl)-5-(pyridin-4-yl)-1H-1,2,3-triazol-4-yl)-3-(2-chlorobenzoyl)pyridine(2-(1-(3,5-bis(trifluoromethyl)benzyl)-5-(pyridin-4-yl)-1H-1,2,3-triazol-4-yl)pyridin-3-yl)(2-chlorophenyl)methanoneMFCD28127604[2-[1-[[3,5-bis(trifluoromethyl)phenyl]methyl]-5-(4-pyridinyl)-1H-1,2,3-triazol-4-yl]-3-pyridinyl](2-chlorophenyl)MethanoneVLY686UNII-NY0COC51FI

데이터베이스 식별자

CAS
622370-35-8
PubChem CID
9916461
DTXSID
DTXSID801045805
ChEMBL
CHEMBL3544984
UNII
NY0COC51FI
Nikkaji
J3.048.437A

물성

구조 계산 물성보충 중

XLogP
6.2
극성 표면적
73.6 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
11
회전 가능 결합 수
6
무거운 원자 수
41
형식 전하
0
복잡도
865

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Listed in ZINC15
Human Drugs · 3건

Breast Feeding; Lactation; Milk, Human; Antiemetics; Neurokinin-1 Receptor Antagonists

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

물리화학적 성질

녹는점
143 · 143 - 145°C
끓는 점
640.9 · 640.9±65.0 °C(Predicted)
밀도
1.45 · 1.45±0.1 g/cm3(Predicted)
저장 조건
-20 °C · Hygroscopic, -20°C Freezer, Under inert atmosphere
용해도
클로로포름(약간 용해됨), 에틸아세테이트(약간 용해됨)
물리적 상태
고체
산도 계수 (pKa)
2.92 · 2.92±0.10(Predicted)
색상
페일베이지부터 브라운까지
InChIKey
CAVRKWRKTNINFF-UHFFFAOYSA-N
SMILES
C(C1=CC=CN=C1C1=C(C2C=CN=CC=2)N(CC2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2)N=N1)(C1=CC=CC=C1Cl)=O

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

독성 정보

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

안전 데이터

신호 어
Warning
유해·위험 문구
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드 H302

화학 및 산업

약리 정보

Protein BindingTradipitant plasma protein binding ranged from 96% to >99% in vitro.
Pharmacodynamics · 1건

Tradipitant inhibits the NK-1 receptor with a Ki of 0.062 nM and effectively blocks Substance P-induced intracellular calcium mobilization. The drug crosses the blood-brain barrier and achieves high receptor occupancy; a clinical study demonstrated that tradipitant occupies approximately 93% of NK-1 receptors in the frontal cortex following multiple doses. In clinical trials involving preventing vomiting induced by motion, single oral doses of 85 mg and 170 mg demonstrated significant efficacy in reducing vomiting incidence compared to placebo, with effects observed in variable sea conditions. At the maximum recommended single dose of 170 mg, tradipitant does not cause clinically significant prolongation of the QTc interval.

Mechanism of Action · 1건

Tradipitant is a selective, high-affinity antagonist of the human substance P/neurokinin-1 (NK-1) receptor. NK-1 receptors are widely distributed in the central nervous system, particularly in brainstem nuclei such as the nucleus tractus solitarius (NTS) and the area postrema, which play a critical role in the regulation of vomiting, as well as in the peripheral gastrointestinal tract. Tradipitant works by blocking the binding of Substance P, the endogenous ligand, to NK-1 receptors, thereby inhibiting the transmission of emetogenic sensory signals from vestibular and visceral sources to the vomiting center. Unlike some other anti-emetics, tradipitant does not exhibit affinity for serotonin (5-HT3), dopamine (D2), cholinergic, or histamine (H1) receptors.

Biological Half-LifeThe observed mean elimination half-life for tradipitant is approximately 34 hours.
Metabolism/Metabolites · 1건

Tradipitant is extensively metabolized; however, the metabolic pathways have not been fully characterized. In vitro findings suggest that non-CYP450-mediated processes and CYP enzymes (CYP3A4, CYP2C19, and to a lesser extent by CYP2C8) are involved in the metabolism of tradipitant. Tradipitant is also glucuronidated by UGT1A4 and UGT2B7. Four major metabolites (M2, M3, M4, and M8) were identified in plasma. Following a single dose of 85 mg tradipitant in healthy subjects under fasting conditions, the AUCs of M2, M3, M4, and M8 represent 40%, 33%, 43%, and 42% of the parent AUC, respectively. The major metabolites of tradipitant (M2, M3, M4, and M8) exhibited NK-1 receptor binding affinities comparable to those of the parent drug.

Absorption, Distribution and Excretion · 4건

Absolute oral bioavailability has not been studied in humans. Following a single dose of 85 mg tradipitant in healthy subjects under fasting conditions, tradipitant geometric mean Cmax was 84.7 ng/mL, AUC0-inf was 1839 ng x h/mL, and the median Tmax was 2.0 hours. Following a single dose of 170 mg tradipitant in healthy subjects under fasting conditions, tradipitant geometric mean Cmax was 112 ng/mL, AUC0-inf was 3,526 ng x h/mL, and the median Tmax was 1.50 hours. In healthy subjects, a high-fat meal increased AUC0-inf and Cmax, while delaying Tmax.

Following a single oral dose of radiolabeled tradipitant 25 mg, approximately 88% of the dose was recovered, with 80% of the dose in feces and 7% in urine. Unchanged tradipitant was minimal in feces and was not detected in urine.

The apparent volume of distribution (Vd/F) of tradipitant is 1956 L in healthy subjects.

The apparent oral clearance of tradipitant is 41.7 L/hour in healthy subjects.

응용 분야

용도Tradipitant, is a neurokinin-1 (NK-1) antagonist.

관련 반응

7건
반응 기록 만들기
HRID 130680 반응식
HRID 130680생성물로
HRID 130681 반응식
HRID 130681생성물로
HRID 1620793 반응식
HRID 1620793생성물로
HRID 2251994 반응식
HRID 2251994반응물로
HRID 2251999 반응식
HRID 2251999생성물로
HRID 2325569 반응식
HRID 2325569반응물로
HRID 2336080 반응식
HRID 2336080생성물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트